Edwards SAPIEN 3 PPI Registry (Conduct)
Edwards SAPIEN 3 PPI Registry - A Retrospective Survey and Prospective Identification of Procedure Related Variables Associated With Permanent Pacemaker Implantation in Patients Receiving an Edwards SAPIEN 3 Valve
Sponsor: Edwards Lifesciences
A observational or N/A phase clinical study on AV Block and Aortic Valve Stenosis, this trial is completed. The trial is conducted by Edwards Lifesciences and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Oct 2020 — Jan 2021 [monthly]
Completed
-
Apr 2019 — Oct 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 5 earlier versions
-
Mar 2019 — Apr 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2018 — Mar 2019 [monthly]
Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting
-
May 2018 — Jun 2018 [monthly]
Not Yet Recruiting
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
- Institut für Pharmakologie und Präventive Medizin
For direct contact, visit the study record on ClinicalTrials.gov .